{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T12:32:54Z","timestamp":1696595574018},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10014-012-0111-3","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T06:08:28Z","timestamp":1341036508000},"page":"99-103","source":"Crossref","is-referenced-by-count":2,"title":["Infratentorial low-grade oligoastrocytoma with aggressive clinical behavior in an adult: a case report with genetic characterization"],"prefix":"10.1007","volume":"30","author":[{"given":"Keisho","family":"Sano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hikaru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Mikami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Hirato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunari","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,1]]},"reference":[{"key":"111_CR1","first-page":"355","volume":"36","author":"H Sasaki","year":"2008","unstructured":"Sasaki H, Yoshida K, Kawase T (2008) Genetic diagnoses and individualized treatment of gliomas. No Shinkei Geka 36:355\u2013369","journal-title":"No Shinkei Geka"},{"key":"111_CR2","first-page":"53","volume-title":"WHO classification of tumors of the central nervous system","author":"G Reifenberger","year":"2007","unstructured":"Reifenberger G, Kros JM, Louis DN et al (2007) Oligodendroglial tumors. In: Louis DN, Ohgaki H, Wiestler OD et al (eds) WHO classification of tumors of the central nervous system. IARC, Lyon, p 53"},{"key":"111_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1525-1578(10)60653-8","volume":"3","author":"Y Hirose","year":"2001","unstructured":"Hirose Y, Aldape K, Takahashi M et al (2001) Tissue microdissection and degenerate oligonucleotide primed polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diagn 3:62\u201367","journal-title":"J Mol Diagn"},{"key":"111_CR4","first-page":"1101","volume":"4","author":"T Ezaki","year":"2011","unstructured":"Ezaki T, Sasaki H, Hirose Y et al (2011) Molecular characteristics of pediatric non-ependymal, non-pilocytic gliomas associated with resistance to temozolomide. Mol Med Rep 4:1101\u20131105","journal-title":"Mol Med Rep"},{"key":"111_CR5","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","volume":"174","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Nobusawa S, Kleihues P et al (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149\u20131153","journal-title":"Am J Pathol"},{"key":"111_CR6","first-page":"1175","volume":"145","author":"J Reifenberger","year":"1994","unstructured":"Reifenberger J, Reifenberger G, Liu L et al (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175\u20131190","journal-title":"Am J Pathol"},{"key":"111_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(02)00791-4","volume":"142","author":"Y Hirose","year":"2003","unstructured":"Hirose Y, Aldape KD, Chang S et al (2003) Grade II astrocytomas are subgrouped by chromosomal aberrations. Cancer Genet Cytogenet 142:1\u20137","journal-title":"Cancer Genet Cytogenet"},{"key":"111_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00401-004-0861-z","volume":"108","author":"Y Okamoto","year":"2004","unstructured":"Okamoto Y, Patre PD, Burkhard C et al (2004) Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108:49\u201356","journal-title":"Acta Neuropathol"},{"key":"111_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11060-008-9714-2","volume":"91","author":"T Miwa","year":"2009","unstructured":"Miwa T, Hirose Y, Sasaki H et al (2009) Genetic characterization of adult infratentorial gliomas. J Neurooncol 91:251\u2013255","journal-title":"J Neurooncol"},{"key":"111_CR10","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/ijc.22574","volume":"120","author":"D Trost","year":"2007","unstructured":"Trost D, Ehrler M, Fimmers R et al (2007) Identification of genomic aberrations associated with shorter overall survival in patients with oligodendroglial tumors. Int J Cancer 120:2368\u20132376","journal-title":"Int J Cancer"},{"key":"111_CR11","first-page":"7683","volume":"61","author":"S Kunwar","year":"2001","unstructured":"Kunwar S, Mohapatra G, Bollen A et al (2001) Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. Cancer Res 61:7683\u20137688","journal-title":"Cancer Res"},{"key":"111_CR12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1227\/NEU.0b013e318212bcd8","volume":"69","author":"Y Hirose","year":"2011","unstructured":"Hirose Y, Sasaki H, Miwa T et al (2011) Whole genome analysis from microdissected tissue revealed adult supratentorial grade II\u2013III gliomas are divided into clinically relevant subgroups by genetic profile. Neurosurgery 69:376\u2013390","journal-title":"Neurosurgery"},{"key":"111_CR13","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1200\/JCO.2006.06.3891","volume":"24","author":"AA Brandes","year":"2006","unstructured":"Brandes AA, Tosoni A, Cavallo G et al (2006) Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol 24:4746\u20134753","journal-title":"J Clin Oncol"},{"key":"111_CR14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1212\/01.wnl.0000262034.26310.a2","volume":"68","author":"G Kaloshi","year":"2007","unstructured":"Kaloshi G, Benouaich-Amiel A, Diakite F et al (2007) Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome. Neurology 68:1831\u20131836","journal-title":"Neurology"},{"key":"111_CR15","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1056\/NEJM200011093431901","volume":"343","author":"M Esteller","year":"2000","unstructured":"Esteller M, Garcia-Foncillas J, Andion E et al (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1740","journal-title":"N Engl J Med"},{"key":"111_CR16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1349-7006.2011.02134.x","volume":"103","author":"Q Songtao","year":"2012","unstructured":"Songtao Q, Lei Y, Si G et al (2012) IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma. Cancer Sci 103:269\u2013273","journal-title":"Cancer Sci"},{"key":"111_CR17","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/cncr.21809","volume":"106","author":"N Levin","year":"2006","unstructured":"Levin N, Lavon I, Zelikovitsh B et al (2006) Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression. Cancer 106:1759\u20131765","journal-title":"Cancer"},{"key":"111_CR18","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.1200\/JCO.2009.24.1034","volume":"27","author":"MJ Bent van den","year":"2009","unstructured":"van den Bent MJ, Dubbink HJ, Sanson M et al (2009) MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. J Clin Oncol 27:5881\u20135886","journal-title":"J Clin Oncol"},{"key":"111_CR19","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1158\/1078-0432.CCR-09-2902","volume":"16","author":"MJ Bent van den","year":"2010","unstructured":"van den Bent MJ, Dubbink HJ, Marie Y et al (2010) IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clin Cancer Res 16:1597\u20131604","journal-title":"Clin Cancer Res"},{"key":"111_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-012-0111-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-012-0111-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-012-0111-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T12:34:13Z","timestamp":1559133253000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-012-0111-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,1]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1007\/s10014-012-0111-3","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,1]]}}}